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EGLN1 gene is located on chromosome 1, location 
229568054-229627413. Gene spans 61293 bases and 
has 5 exons. 
Transcription 
PHD2 expression is strongly induced in hypoxia by the 
HIF-1alpha transcription factor. Primary transcript 
length is 5936 bases. On mRNA level two splice 
variants have been proposed, lacking exons 3 or 4, but 
these have not been confirmed on protein level. 
Protein 
Description 
PHD2 protein is 426 amino acids long and 
approximately 46 kDa. It has a zf-MYND domain (aa 







PHD2 is a member of the 2-oxoglutarate-dependent, 
non-haem iron binding dioxygenases. 
PHD2 post-translationally regulates the levels of  
hypoxia-inducible factor-alpha (HIF-alpha) subunits in 
normoxic conditions by hydroxylating them in an 
oxygen-dependant manner on specific proline residues. 
This enables recognition of HIF by the VHL ubiquitin 
ligase complex and subsequent degradation of HIF by 
the proteasome. In hypoxic conditions the 
hydroxylation is significantly decreased, and the HIF-
alpha subunits are stabilized. PHD2 is considered the 
main HIF-1alpha regulator in normoxic and mildly 
hypoxic conditions. 
Homology 
EGLN1 has two paralogs: EGLN2 and EGLN3 
homologs have been found in all multicellular 
organisms investigated. 
Mutations 
Note: Homozygous deletion confers embryonic 
lethality in mouse. 
Germinal 
Heterozygous mutations have been associated with 
familial erythrocytosis. Currently three point mutations: 
G1112A → Arg371His, C950G → Pro317Arg, 
C1129T → Gln377X, one deletion: 606delG → 
frameshift, and one insertion: 840_841insA → 
frameshift have been reported. 
Implicated in 
Familial erythrocytosis (ECYT3) 
Note: ECYT3 is characterized by increased serum 
hemoglobin and hematocrit, but with normal serum 
erythropoietin levels. 
Disease 
Characterized EGLN1 mutations result in the loss of 
catalytic function and thereby aberrant erythropoietin 
expression. 






Atlas Genet Cytogenet Oncol Haematol. 2008;12(5)  366 
Head and neck squamous cell 
carcinoma 
Note: Increased expression levels and nuclear 
translocation have been associated with the 
aggressiveness of the carcinoma. 
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